What is Bone Health Technologies?
Bone Health Technologies is the developer of Osteoboost, a pioneering, FDA-cleared wearable therapy designed to address bone loss in the spine and hip. By utilizing vibration therapy inspired by NASA research, the company provides a non-drug alternative for patients seeking to maintain bone strength and density. The firm operates at the intersection of digital health and medical device engineering, targeting a critical demographic that requires accessible, daily-use solutions to manage long-term skeletal health. Their market position is bolstered by clinical evidence demonstrating the efficacy of their technology in mitigating the physiological impacts of osteopenia.
How much funding has Bone Health Technologies raised?
Bone Health Technologies has raised a total of $7.5M across 2 funding rounds:
Unspecified
$2.5M
Other Financing Round
$5M
Unspecified (2021): $2.5M with participation from Portfolia Femtech Fund, Ambit Health Ventures, Good Growth Capital, Astia, and IT-Farm
Other Financing Round (2024): $5M led by Berkeley Catalyst Fund, Esplanade Ventures, and Terumo
Key Investors in Bone Health Technologies
Esplanade Ventures
Esplanade Ventures is Canada's leading digital health venture capital firm, specializing in early-stage investments in technology companies that are transforming healthcare in the U.S. and Canada.
Terumo
Terumo is a global medical device company originating from Japan that pursues reliable quality and advanced technology to contribute to healthcare across countries and regions worldwide.
Berkeley Catalyst Fund
Berkeley Catalyst Fund is a venture capital firm that provides essential benefits and capital to entrepreneurial startups.
What's next for Bone Health Technologies?
With the support of its latest strategic backers, Bone Health Technologies is poised to scale its manufacturing and distribution capabilities to meet growing demand. The company's roadmap likely includes expanding its clinical research initiatives to further validate the long-term benefits of its wearable therapy and exploring potential integrations within broader healthcare delivery systems. As the firm transitions into this next phase of growth, the focus will remain on enhancing patient outcomes through technological innovation and strategic partnerships with global medical device leaders. This capital infusion provides the necessary runway to navigate regulatory landscapes and penetrate new geographic markets, ensuring that their unique therapeutic approach becomes a standard of care for bone health management.
See full Bone Health Technologies company page
